EG11061A - Process for preparation of 3-fluorocephalosporins - Google Patents

Process for preparation of 3-fluorocephalosporins

Info

Publication number
EG11061A
EG11061A EG169/74A EG16974A EG11061A EG 11061 A EG11061 A EG 11061A EG 169/74 A EG169/74 A EG 169/74A EG 16974 A EG16974 A EG 16974A EG 11061 A EG11061 A EG 11061A
Authority
EG
Egypt
Prior art keywords
fluorocephalosporins
preparation
Prior art date
Application number
EG169/74A
Other languages
English (en)
Inventor
G Koppel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of EG11061A publication Critical patent/EG11061A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EG169/74A 1974-02-06 1974-05-13 Process for preparation of 3-fluorocephalosporins EG11061A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US439206A US3926978A (en) 1974-02-06 1974-02-06 Process for preparing 3-fluorocephalosporins

Publications (1)

Publication Number Publication Date
EG11061A true EG11061A (en) 1976-11-30

Family

ID=23743733

Family Applications (1)

Application Number Title Priority Date Filing Date
EG169/74A EG11061A (en) 1974-02-06 1974-05-13 Process for preparation of 3-fluorocephalosporins

Country Status (32)

Country Link
US (1) US3926978A (xx)
JP (1) JPS612678B2 (xx)
AR (1) AR202209A1 (xx)
AT (1) AT329181B (xx)
BE (1) BE813169A (xx)
BG (1) BG25091A3 (xx)
BR (1) BR7404085A (xx)
CA (1) CA1017741A (xx)
CH (1) CH598263A5 (xx)
DD (1) DD117465A5 (xx)
DE (1) DE2417988A1 (xx)
DK (1) DK119874A (xx)
EG (1) EG11061A (xx)
ES (1) ES427235A1 (xx)
FI (1) FI99474A (xx)
FR (1) FR2259826B1 (xx)
GB (1) GB1462944A (xx)
GT (1) GT197432532A (xx)
HU (1) HU167748B (xx)
IE (1) IE38980B1 (xx)
IL (1) IL44361A (xx)
IN (1) IN139927B (xx)
MW (1) MW1074A1 (xx)
NL (1) NL7403126A (xx)
NO (1) NO741093L (xx)
OA (1) OA04641A (xx)
PH (1) PH12616A (xx)
PL (1) PL90989B1 (xx)
RO (1) RO63021A (xx)
SE (1) SE411453B (xx)
ZA (1) ZA741423B (xx)
ZM (1) ZM5674A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208515A (en) * 1973-02-23 1980-06-17 Eli Lilly And Company 3-Halo cephalosporins
US4064343A (en) * 1974-04-01 1977-12-20 Eli Lilly And Company 3-Halo cephalosporins
US4260745A (en) * 1979-10-12 1981-04-07 Eli Lilly And Company 3-Halo cephalosporins
US4281116A (en) * 1979-10-12 1981-07-28 Eli Lilly And Company 3-Halo cephalosporins
US4252950A (en) * 1979-10-12 1981-02-24 Eli Lilly And Company 3-Halo cephalosporins
DE3851449T2 (de) * 1987-02-27 1995-03-16 Banyu Pharma Co Ltd Cephalosporinderivate, Verfahren zu ihrer Herstellung und antibakterielle Mittel.
JPH0343723A (ja) * 1989-07-11 1991-02-25 Japan Servo Co Ltd 投影器
WO1993011132A1 (de) * 1991-12-06 1993-06-10 Ciba-Geigy Ag Verfahren zur herstellung des antibiotikums cefaclor
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830808A (en) * 1968-06-14 1974-08-20 Glaxo Lab Ltd Cephalosporins having a thioetherified methyl group at the 3-position
GB1377651A (en) * 1971-01-12 1974-12-18 Glaxo Lab Ltd Esters

Also Published As

Publication number Publication date
ES427235A1 (es) 1976-07-16
FI99474A (xx) 1975-08-07
IL44361A0 (en) 1974-06-30
DK119874A (xx) 1975-09-29
IE38980B1 (en) 1978-07-05
DE2417988A1 (de) 1975-08-07
CA1017741A (en) 1977-09-20
IN139927B (xx) 1976-08-21
ATA312174A (de) 1975-07-15
FR2259826A1 (xx) 1975-08-29
MW1074A1 (en) 1975-07-09
SE411453B (sv) 1979-12-27
SE7403307L (xx) 1975-08-07
GB1462944A (en) 1977-01-26
JPS612678B2 (xx) 1986-01-27
AU6640374A (en) 1975-09-11
JPS50108287A (xx) 1975-08-26
US3926978A (en) 1975-12-16
AT329181B (de) 1976-04-26
OA04641A (fr) 1980-07-31
GT197432532A (es) 1975-09-25
ZA741423B (en) 1975-10-29
AR202209A1 (es) 1975-05-23
BR7404085A (pt) 1976-01-27
IL44361A (en) 1977-07-31
FR2259826B1 (xx) 1977-06-24
IE38980L (en) 1975-08-06
BG25091A3 (en) 1978-07-12
PH12616A (en) 1979-07-05
RO63021A (fr) 1978-05-15
NL7403126A (nl) 1975-08-08
HU167748B (xx) 1975-12-25
ZM5674A1 (en) 1977-04-21
NO741093L (xx) 1975-09-01
BE813169A (fr) 1974-10-02
CH598263A5 (xx) 1978-04-28
DD117465A5 (xx) 1976-01-12
PL90989B1 (xx) 1977-02-28

Similar Documents

Publication Publication Date Title
GB1536407A (en) Process for the preparation of bis-indolic compounds
HU171684B (hu) Sposob poluchenija proizvodnykh 18-metil-19-nor-20-okso-pregnana
HU171804B (hu) Sposob poluchenija proizvodnykh 7-metoksi-6-tiatetraciklina
EG11666A (en) Process for preparation of a-6-deoxy-5-hydroxytetracyclin
EG11061A (en) Process for preparation of 3-fluorocephalosporins
ZA753180B (en) Process for preparation of abietamide derivatives
CH613193A5 (en) Process for the preparation of novel 2-arylamino-2-imidazoline derivatives
CH613683A5 (en) Process for the preparation of secoprostaglandins
IL48062A0 (en) Process for the preparation of metasubstituted halogenophenols
GR60310B (en) Preparation process of 11-desoxy-15-substituted-omega-pentanorprostaglandins
CH614194A5 (en) Process for the preparation of 5-aroyl- and 5-thenoyl-pyrrole compounds
GB1519826A (en) Process for the preparation of 11 - hydroxy - 18 - alkylestrane compounds
ZA75976B (en) Process for the preparation of cis-vincamine
CH612932A5 (en) Process for the preparation of alkylsulphonylphenoxy-propanolamines
ZM11375A1 (en) Process for the preparation of poly-(-n-alkyliminoalanes)
CH611273A5 (en) Process for the preparation of novel 3-oxocyclohex-1-en-1-yl- ureas
JPS52244A (en) Process for manufacture of pseudotrisaccharides
KR780000607B1 (en) Process for preparation of n-phenylpyroles
ZA753469B (en) Process for the preparation of alpha-diol-alpha-dioxo compounds
CH613206A5 (en) Process for the preparation of 1-aminomethyl-6-phenyltriazolobenzodiazepine compounds
KR780000605B1 (en) Process for preparation of panthethine
KR780000608B1 (en) Process for preparation of pyridinie dirivatives
KR780000430B1 (en) Process for preparation of substituted 4-hydroxy-3-nitrocoumarin
IL47243A0 (en) Process for the preparation of 4-hydroxypyrimidines
IL48633A0 (en) Process for the preparation of trichlorothiazole